EBV-TCR-T (YT-E001) cells
HXYT-001
Phase 2 mab active
Quick answer
EBV-TCR-T (YT-E001) cells for Nasopharyngeal Carcinoma is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Nasopharyngeal Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active